Sword Health Raises $163M And Reaches $2B Valuation As The Fastest Growing Digital Msk Company
Amount Raised
$163 Million
Description
SWORD Health, the most clinical and comprehensive digital musculoskeletal (MSK) solution in the market, today announced its Series D funding round led by Sapphire Ventures, a leading global technology-focused venture capital firm with participation from new investors Sozo Ventures, Willoughby Capital, ADQ and Localglobe, and from all major investors including General Catalyst, Khosla Ventures, Founders Fund, Bond, Transformation Capital, and Green Innovations. This brings the total primary and secondary transactions to more than $320M invested in SWORD, with the current round valued at $1.8B, catapulting it to healthtech unicorn status. The primary funding round of $163M was heavily oversubscribed, resulting in investors purchasing an additional $26M, in a secondary transaction which propelled the valuation to $2B.